Radioimmunoscintigraphy in patients with breast adenocarcinoma using technetium-99m labelled monoclonal antibody 170H.82: report of a phase II study

S. A. McQuarrie; G. D. MacLean; G. R. Boniface; K. Golberg; A. J. B. McEwan

doi:10.1007/s002590050066

Radioimmunoscintigraphy in patients with breast adenocarcinoma using technetium-99m labelled monoclonal antibody 170H.82: report of a phase II study

European Journal of Nuclear Medicine and Molecular Imaging ◽

10.1007/s002590050066 ◽

1997 ◽

Vol 24 (4) ◽

pp. 381-389 ◽

Cited By ~ 1

Author(s):

S. A. McQuarrie ◽

G. D. MacLean ◽

G. R. Boniface ◽

K. Golberg ◽

A. J. B. McEwan

Keyword(s):

Monoclonal Antibody ◽

Phase Ii ◽

Phase Ii Study ◽

Breast Adenocarcinoma ◽

Technetium 99M

Download Full-text

Radioimmunoscintigraphy in patients with breast adenocarcinoma using technetium-99m labelled monoclonal antibody 170H.82: Report of a phase II study

European Journal of Nuclear Medicine ◽

10.1007/bf00881809 ◽

1997 ◽

Vol 24 (4) ◽

pp. 381-389

Author(s):

S. A. McQuarrie ◽

G. D. MacLean ◽

G. R. Boniface ◽

K. Golberg ◽

A. J. B. McEwan

Keyword(s):

Monoclonal Antibody ◽

Phase Ii ◽

Phase Ii Study ◽

Breast Adenocarcinoma ◽

Technetium 99M

Download Full-text

12 Phase II study of lutetium-177-labeled anti carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma

European Urology Supplements ◽

10.1016/s1569-9056(15)60015-x ◽

2015 ◽

Vol 14 (2) ◽

pp. e12 ◽

Cited By ~ 2

Author(s):

C.H.J. Muselaers ◽

T.J. Van Oostenbrugge ◽

M.J. Boers-Sonderen ◽

O.C. Boerman ◽

I.M.E. Desar ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Monoclonal Antibody ◽

Carbonic Anhydrase ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Phase Ii Study ◽

Carbonic Anhydrase Ix ◽

Advanced Renal Cell Carcinoma

Download Full-text

Sirukumab, a human anti-interleukin-6 monoclonal antibody: a randomised, 2-part (proof-of-concept and dose-finding), phase II study in patients with active rheumatoid arthritis despite methotrexate therapy

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-205137 ◽

2014 ◽

Vol 73 (9) ◽

pp. 1616-1625 ◽

Cited By ~ 110

Author(s):

Josef S Smolen ◽

Michael E Weinblatt ◽

Shihong Sheng ◽

Yanli Zhuang ◽

Benjamin Hsu

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Phase Ii ◽

Interleukin 6 ◽

Active Rheumatoid Arthritis ◽

Phase Ii Study ◽

Methotrexate Therapy ◽

Dose Finding ◽

Proof Of Concept

Download Full-text

Abstract CT158: Phase II study of monalizumab, a first-in-class NKG2A monoclonal antibody, in combination with cetuximab in previously treated recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Preliminary assessment of safety and efficacy

10.1158/1538-7445.am2018-ct158 ◽

2018 ◽

Cited By ~ 3

Author(s):

Roger Cohen ◽

Jérôme Fayette ◽

Marshall Posner ◽

Gautier Lefebvre ◽

Jessica Bauman ◽

...

Keyword(s):

Monoclonal Antibody ◽

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Phase Ii Study ◽

Preliminary Assessment ◽

Safety And Efficacy ◽

Metastatic Squamous Cell Carcinoma ◽

Previously Treated

Download Full-text

A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors

Annals of Oncology ◽

10.1093/annonc/mdw659 ◽

2017 ◽

Vol 28 (3) ◽

pp. 541-546 ◽

Cited By ~ 27

Author(s):

A.J. Wagner ◽

H. Kindler ◽

H. Gelderblom ◽

P. Schöffski ◽

S. Bauer ◽

...

Keyword(s):

Monoclonal Antibody ◽

Phase Ii ◽

Gastrointestinal Stromal Tumors ◽

Phase Ii Study ◽

Stromal Tumors ◽

Previously Treated Patients ◽

Previously Treated

Download Full-text

Efficacy and safety of farletuzumab, a humanized monoclonal antibody to folate receptor alpha, in platinum-sensitive relapsed ovarian cancer subjects: Final data from a multicenter phase II study.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.5001 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 5001-5001 ◽

Cited By ~ 11

Author(s):

A. J. White ◽

R. L. Coleman ◽

D. K. Armstrong ◽

D. Glenn ◽

A. Bicher ◽

...

Keyword(s):

Ovarian Cancer ◽

Monoclonal Antibody ◽

Phase Ii ◽

Phase Ii Study ◽

Folate Receptor ◽

Efficacy And Safety ◽

Platinum Sensitive ◽

Multicenter Phase ◽

Humanized Monoclonal Antibody ◽

Final Data

Download Full-text

Randomized phase II study of ficlatuzumab (formerly AV-299), an anti-hepatocyte growth factor (HGF) monoclonal antibody (MAb) in combination with gefitinib (G) in Asian patients (pts) with NSCLC.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.tps213 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. TPS213-TPS213 ◽

Cited By ~ 8

Author(s):

T. Mok ◽

E. Tan ◽

K. Park ◽

J. Jac ◽

M. Han ◽

...

Keyword(s):

Monoclonal Antibody ◽

Growth Factor ◽

Hepatocyte Growth Factor ◽

Phase Ii ◽

Phase Ii Study ◽

Asian Patients ◽

Randomized Phase Ii ◽

Hepatocyte Growth

Download Full-text

A randomized, phase II study of the anti‐insulin‐like growth factor receptor type 1 (IGF‐1R) monoclonal antibody robatumumab (SCH 717454) in patients with advanced colorectal cancer

Cancer Medicine ◽

10.1002/cam4.263 ◽

2014 ◽

Vol 3 (4) ◽

pp. 988-997 ◽

Cited By ~ 9

Author(s):

Edward H. Lin ◽

Heinz‐Josef Lenz ◽

Mansoor N. Saleh ◽

Mary J. Mackenzie ◽

James A. Knost ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Growth Factor ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Phase Ii Study ◽

Growth Factor Receptor ◽

Receptor Type ◽

Randomized Phase Ii

Download Full-text

3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study.

International Journal of Oncology ◽

10.3892/ijo.12.6.1299 ◽

1998 ◽

Cited By ~ 8

Author(s):

N K Cheung ◽

B H Kushner ◽

S D Yeh ◽

S M Larson

Keyword(s):

Monoclonal Antibody ◽

Phase Ii ◽

Phase Ii Study ◽

Antibody Treatment ◽

Stage 4 ◽

Monoclonal Antibody Treatment

Download Full-text

Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non–Small-Cell Lung Cancer

Yearbook of Oncology ◽

10.1016/j.yonc.2012.06.009 ◽

2012 ◽

Vol 2012 ◽

pp. 193-194

Author(s):

A.S. Tsao

Keyword(s):

Lung Cancer ◽

Monoclonal Antibody ◽

Growth Factor ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Advanced Stage ◽

Small Cell Lung ◽

Randomized Phase Ii

Download Full-text